Since the first kidney transplant was performed in 1954 immense progress has been made in the world of transplantation. Modern immunosuppressive regimens have led to increasing graft and patient survival after solid organ transplantation. Furthermore, these advances have opened the door to new fields of transplantation such as composite tissue allotransplantation. These developments have made possible numerous types of transplantation including, but not limited to face, penile, and uterine transplantation. Moreover, innovations in genetic engineering and stem cell technology have contributed to rapid developments in the fields of xenotransplantation and the engineering of functional organs from induced pluripotent stem cells. As the prevalence of chronic diseases rises, so too will the necessity for organ transplantation. Thus, the transplant innovations of the modern era need to be expanded upon so as to continue to discover new ways to address organ shortages and the complications of transplantation.
References
[1]
Murray, J.E., Merrill, J.P. and Harrison, J.H. (1955) Renal Homotransplantation in Identical Twins. Surgical Forum, 6, 432-436.
[2]
Hamburger, J., Vaysse, J., Crosnier, J., Tubiana, M., Lalanne, C.M., Antoine, B., Auvert, J., Soulier, J.P., Dormont, J., Salmon, C., et al. (1959) Transplantation of a Kidney between Non-Monozygotic Twins after Irradiation of the Receiver: Good Function at the Fourth Month. Presse Medicale, 67, 1771-1775.
[3]
Calne, R.Y. (1960) The Rejection of Renal Homografts: Inhibition in Dogs by 6-Mercaptopurine. Lancet, 1, 417-418. https://doi.org/10.1016/S0140-6736(60)90343-3
[4]
Goodwin, W.E. and Martin, E.C. (1963) Transplantation of the Kidney. Urological Survey, 13, 229-248
[5]
Starzl, T.E., Marchioro, T.L. and Waddell, W.R. (1963) The Reversal of Rejection in Human Renal Homografts with Subsequent Development of Homograft Tolerance. Surgery, Gynecology & Obstetrics, 117, 385-395.
[6]
Starzl, T.E., Weil III, R., Iwatsuki, S., Klintmalm, G., Schroter, G.P.J., Koep, L.J., Iwaki, Y., Terasaki, P.I. and Porter, K.A. (1980) The Use of Cyclosporin A and Prednisone in Cadaver Kidney Transplantation. Surgery, Gynecology & Obstetrics, 151, 17-26.
[7]
Mahmud, N., Klipa, D. and Ahsan, N. (2010) Antibody Immunosuppressive Therapy in Solid Organ Transplant: Part I. mAbs, 2, 148-156. https://doi.org/10.4161/mabs.2.2.11159
[8]
Salvatori, M., et al. (2015) Semi-Xenotransplantation: The Regenerative Medicine-Based Approach to Immunosuppression-Free Transplantation and to Meet the Organ Demand. Xenotransplantation, 22, 1-6. https://doi.org/10.1111/xen.12122
[9]
Giuglea, C., Coman, C., Marinescu, S., Florescu, I. and Lascar, I. (2013) Transplantation of Composite Tissue Allograft: Scientific Bases and Clinical Applications. Journal of Medicine and Life, 6, 40-44.
Dubernard, J.M., Owen, E., Herzberg, G., et al. (1999) Human Hand Allograft: Report on First 6 Months. The Lancet, 353, 1315-1320. https://doi.org/10.1016/S0140-6736(99)02062-0
[12]
Siemionow, M. (2016) The Miracle of Face Transplantation after 10 Years. British Medical Bulletin, 120, 5-14. https://doi.org/10.1093/bmb/ldw045
[13]
Siemionow, M. and Ozturk, C. (2012) Face Transplantation: Outcomes, Concerns, Controversies, and Future Directions. Journal of Craniofacial Surgery, 23, 254-259. https://doi.org/10.1097/SCS.0b013e318241b920
[14]
Stokes, M. (2016) A Decade of Face Transplantation: Lessons Learned and What Lies Ahead. Plastic Surgery News, 24-25.
[15]
Siemionow, M., Papy, F., Alam, D., et al. (2009) Near-Total Human Face Transplantation for a Severely Disfigured Patient in the USA. The Lancet, 374, 203-209. https://doi.org/10.1016/S0140-6736(09)61155-7
[16]
Infante-Cossio, P., Barrera-Pulido, F., Gomez-Cia, T., Sicilia-Castro, D., Garcia-Perla-Garcia, A., Gacto-Sanchez, P., et al. (2016) Facial Transplantation: A Concise Update. Medicina Oral, Patologia Oral Y Cirugia Bucal, 18, 263-271.
[17]
Paradis, C., Siemionow, M., Papay, F., et al. (2010) Ethical Considerations in the First American Face Transplant. Plastic and Reconstructive Surgery, 126, 896-901. https://doi.org/10.1097/PRS.0b013e3181e3b63d
[18]
Coffman, K.L. and Siemionow, M.Z. (2014) Ethics of Facial Transplantation Revisited. Current Opinion in Organ Transplantation, 19, 181-187. https://doi.org/10.1097/MOT.0000000000000058
[19]
Siemionow, M., Gatherwright, J., Djohan, R., et al. (2011) Cost Analysis of Conventional Facial Reconstruction Procedures Followed by Face Transplantation. American Journal of Transplantation, 11, 379-385. https://doi.org/10.1111/j.1600-6143.2010.03373.x
[20]
Cetrulo, C.L., Li, K., Salinas, H.M., Treiser, M.D., Schol, I., Barrisford, G.W. and Ko, D.S.C. (2017) Penis Transplantation: First US Experience. Annals of Surgery, 267, 983-988. https://doi.org/10.1097/SLA.0000000000002241
[21]
Johannesson, L. and Jarvholm, S. (2016) Uterus Transplantation: Current Progress and Future Prospects. International Journal of Women’s Health, 8, 43-51. https://doi.org/10.2147/IJWH.S75635
[22]
Castellón, L.A.R., Amador, M.I.G., Gonzalez, R.E.D., Eduardo, M.S.J., Diaz-Garcia, C., Kvarnstrom, N. and Branstrom, M. (2017) The History behind Successful Uterine Transplantation in Humans. JBRA Assisted Reproduction, 21, 126-134. https://doi.org/10.5935/1518-0557.20170028
[23]
http://optn.transplant.hrsa.gov
[24]
Cooper, D.K.C., Ezzelarab, M.B., Hara, H., et al. (2016) The Pathobiology of Pig-to-Primate Xenotransplantation: A Historical Review. Xenotransplantation, 23, 83-105. https://doi.org/10.1111/xen.12219
[25]
Hering, B.J., Wijkstrom, M., Graham, M.L., et al. (2006) Prolonged Diabetes Reversal after Intraportal Xenotransplantation of Wild-Type Porcine Islets in Immunosuppressed Nonhuman Primates. Nature Medicine, 12, 301-303. https://doi.org/10.1038/nm1369
[26]
Cardona, K., Korbutt, G.S., Milas, Z., et al. (2006) Long-Term Survival of Neonatal Porcine Islets in Nonhuman Primates by Targeting Costimulation Pathways. Nature Medicine, 12, 304-306. https://doi.org/10.1038/nm1375
[27]
Martin, C., Plat, M., Nerriére-Daguin, V., et al. (2005) Transgenic Expression of CTLA4-Ig by Fetal Pig Neurons for Xenotransplantation. Transgenic Research, 14, 373-384. https://doi.org/10.1007/s11248-004-7268-4
[28]
Badin, R.A., Padoan, A., Vadori, M., et al. (2010) Longterm Clinical Recovery in Parkinsonian Monkey Recipients of CTLA4-Ig Transgenic Porcine Neural Precursors. Transplantation, 90, 47. https://doi.org/10.1097/00007890-201007272-00090
[29]
Kuwaki, K., Tseng, Y.L., Dor, F.J., et al. (2005) Heart Transplantation in Baboons using Alpha1, 3-Galactosyltransferase Gene-Knockout Pigs as Donors: Initial Experience. Nature Medicine, 11, 29-31. https://doi.org/10.1038/nm1171
[30]
Tseng, Y.L., Kuwaki, K., Dor, F.J., et al. (2005) α 1,3-Galactosyltransferase Gene-Knockout Pig Heart Transplantation in Baboons with Survival Approaching 6 Months. Transplantation, 80, 1493-1500. https://doi.org/10.1097/01.tp.0000181397.41143.fa
[31]
Ekser, B., Li, P. and Cooper, D.K.C. (2017) Xenotransplantation: Past, Present, and Future. Current Opinion in Organ Transplantation, 22, 513-521. https://doi.org/10.1097/MOT.0000000000000463
[32]
Koh, C.J. and Atala, A. (2004) Tissue Engineering, Stem Cells, and Cloning: Opportunities for Regenerative Medicine. Journal of the American Society of Nephrology, 15, 1113-1125. https://doi.org/10.1097/01.ASN.0000119683.59068.F0
[33]
Takahashi, K. and Yamanaka, S. (2006) Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell, 126, 663-676. https://doi.org/10.1016/j.cell.2006.07.024
[34]
Takebe, T., Sekine, K. and Enomura, M. (2013) Vascularized and Functional Human Liver from an iPSC-Derived Organ Bud Transplant. Nature, 499, 481-485. https://doi.org/10.1038/nature12271
[35]
Mandai, M., Watanabe, A., Kurimoto, Y., et al. (2017) Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. NEJM, 376, 1038-1046. https://doi.org/10.1056/NEJMoa1608368
[36]
Collaborators, G.B.D.R.F. (2016) Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet, 388, 1659-1724. https://doi.org/10.1016/S0140-6736(16)31679-8
